Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | NBY |
---|---|---|
09:32 ET | 2113 | 0.7001 |
09:39 ET | 600 | 0.701 |
09:44 ET | 200 | 0.7086 |
09:48 ET | 400 | 0.702922 |
09:50 ET | 100 | 0.7001 |
09:57 ET | 291 | 0.7002 |
10:00 ET | 320 | 0.7 |
10:06 ET | 1000 | 0.691099 |
10:08 ET | 300 | 0.6901 |
10:13 ET | 1028 | 0.6855 |
10:26 ET | 100 | 0.69 |
10:31 ET | 242 | 0.695 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
NovaBay Pharmaceuticals Inc | 3.5M | 0.0x | --- |
CV Sciences Inc | 8.2M | -2.6x | -25.43% |
Sonoma Pharmaceuticals Inc | 3.9M | -0.6x | --- |
Evofem Biosciences Inc | 1.0M | 0.0x | --- |
GSRX Industries Inc | 80.0 | 0.0x | --- |
China Pharma Holdings Inc | 3.4M | -0.5x | --- |
NovaBay Pharmaceuticals, Inc. develops and sells scientifically created and clinically proven eyecare and wound care products. Its product, Avenova Antimicrobial Lid and Lash Solution, has antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. It offers a portfolio of products for each step of the standard at home treatment regimen, including the Avenova Eye Health Support antioxidant-rich oral supplement, Avenova Lubricating Eye Drops for instant relief, NovaWipes by Avenova, Avenova Warm Eye Compress to soothe the eyes, and the i-Chek by Avenova to monitor physical eyelid health. It also manufactures and sells its proprietary form of hypochlorous acid for the wound care market with its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers and other injuries.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.5M |
---|---|
Revenue (TTM) | $11.2M |
Shares Outstanding | 4.9M |
NovaBay Pharmaceuticals Inc does not pay a dividend. | |
Beta | 0.73 |
EPS | $-53.22 |
Book Value | $10.33 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -71.02% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.